GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » Enterprise Value

Beijing Health Guard Biotechnology (BJSE:833575) Enterprise Value : ¥5,664.32 Mil (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Beijing Health Guard Biotechnology's Enterprise Value is ¥5,664.32 Mil. Beijing Health Guard Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-310.99 Mil. Therefore, Beijing Health Guard Biotechnology's EV-to-EBIT ratio for today is -18.21.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Beijing Health Guard Biotechnology's Enterprise Value is ¥5,664.32 Mil. Beijing Health Guard Biotechnology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-310.99 Mil. Therefore, Beijing Health Guard Biotechnology's EV-to-EBITDA ratio for today is -18.21.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Beijing Health Guard Biotechnology's Enterprise Value is ¥5,664.32 Mil. Beijing Health Guard Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.67 Mil. Therefore, Beijing Health Guard Biotechnology's EV-to-Revenue ratio for today is 3,395.88.


Beijing Health Guard Biotechnology Enterprise Value Historical Data

The historical data trend for Beijing Health Guard Biotechnology's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology Enterprise Value Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,837.68 5,911.83 15,158.97 15,861.72 7,551.46

Beijing Health Guard Biotechnology Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,369.48 3,924.26 4,238.10 7,551.46 5,259.77

Competitive Comparison of Beijing Health Guard Biotechnology's Enterprise Value

For the Biotechnology subindustry, Beijing Health Guard Biotechnology's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Health Guard Biotechnology's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Beijing Health Guard Biotechnology's Enterprise Value falls into.



Beijing Health Guard Biotechnology Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Beijing Health Guard Biotechnology's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Beijing Health Guard Biotechnology's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Health Guard Biotechnology  (BJSE:833575) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Beijing Health Guard Biotechnology's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5664.321/-310.987
=-18.21

Beijing Health Guard Biotechnology's current Enterprise Value is ¥5,664.32 Mil.
Beijing Health Guard Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-310.99 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Beijing Health Guard Biotechnology's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=5664.321/-310.987
=-18.21

Beijing Health Guard Biotechnology's current Enterprise Value is ¥5,664.32 Mil.
Beijing Health Guard Biotechnology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-310.99 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Beijing Health Guard Biotechnology's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5664.321/1.668
=3,395.88

Beijing Health Guard Biotechnology's current Enterprise Value is ¥5,664.32 Mil.
Beijing Health Guard Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Health Guard Biotechnology Enterprise Value Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Health Guard Biotechnology (BJSE:833575) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Website
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology (BJSE:833575) Headlines

No Headlines